drugset
drugset / Trial / NCT05452785

A Comparative Bioavailability Study of DFD-29 Capsules 40 mg Versus SOLODYN® Tablets 105 mg, Under Fasting & Fed Conditions in Healthy Adult Human Subjects

NCT05452785 ↗

Phase 1 Completed 24 enrolled Journey Medical Corporation Dr. Reddy's Laboratories Limited · collab
RandomizedCrossoverOpen-labelOther

Summary

Single-center, randomized, open-label, laboratory-blinded, 3-treatment, 3-period, 6-sequence, single-dose, crossover study.

Timeline

Start
2022-05-07
Primary completion
2022-05-25
Completion
2022-05-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Minocycline Small molecule 40 mg Oral
Subject Minocycline Small molecule 105 mg Oral

Indications

No indication recorded.